Drugs / Polyclonal immunoglobulin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04374539 | Apr 2020 → Jun 2021 | COVID-19 | Fundacion Clinic per a la Recerca Biomédica | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyclonal immunoglobulin | “Polyclonal immunoglobulin will be administered at a dose of 100 mg / kg ev after each plasma exchange.” NCT04374539 ↗ |
| Route | Intravenous | “administered at a dose of 100 mg / kg ev” NCT04374539 ↗ |